List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 302 studies with search of:   "Camptothecin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Conditions: Corpus Uteri;   Lung Cancer
Intervention: Drug: 9-NC in aerosol reservoir
2 Completed Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
3 Completed Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: polyglutamate camptothecin
4 Recruiting Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
5 Completed Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Lung Diseases;   Cancer
Intervention: Drug: Liposomal 9-Nitrocamptothecin
6 Completed Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention: Drug: 9-NC in aerosol reservoir
7 Terminated Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Conditions: Cancer of Stomach;   Gastroesophageal Cancer
Intervention: Drug: Pegamotecan
8 Completed Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
Conditions: Corpus Uteri;   Endometrial Cancer
Intervention:
9 Active, not recruiting Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Condition: Cancer
Intervention: Drug: aminocamptothecin colloidal dispersion
10 Completed Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: aminocamptothecin colloidal dispersion
11 Recruiting A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Bevacizumab;   Drug: Temozolomide;   Drug: Vincristine sulfate;   Drug: Irinotecan;   Drug: Cefixime or Cefpodoxime
12 Completed A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
Condition: Ovarian Neoplasms
Intervention: Drug: 9-aminocamptothecin
13 Completed Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia
Conditions: Acute Myeloid Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: 9-Aminocamptothecin (9-AC)
14 Recruiting Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
Conditions: Glioblastoma Multiforme;   Glioma
Interventions: Drug: Thalidomide;   Drug: CPT-11;   Procedure: MRI Scan;   Procedure: Quantitative Sensory Tests (QST)
15 Suspended Efficacy and Safety Evaluation of Pegamotecan (PEG-Camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pegamotecan
16 Completed Nitrocamptothecin in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: rubitecan
17 Completed Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: rubitecan
18 Completed Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rubitecan
19 Completed Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
Conditions: Gastrointestinal Stromal Tumor;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: rubitecan
20 Active, not recruiting Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: rubitecan

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services